Bristol-Myers Squibb (BMY)

Index:

S&P 100

$ 46.20
   
  • Change Today:
    $0.61
  • 52 Week High: $63.11
  • 52 Week Low: $42.60
  • Currency: US Dollars
  • Shares Issued: 2,006.00m
  • Volume: 4,897,687
  • Market Cap: $92,667m
  • RiskGrade: 106
  • Beta: 0.30

BMY Overview

Bristol-Myers Squibb is a global producer and distributor of pharmaceuticals and other healthcare-related products. The merger of Bristol-Myers with Squibb in 1989 created what was then the world’s second-largest pharmaceutical enterprise. The company’s key business areas cover pharmaceuticals, infant formulas and nutritional products, ostomy & advanced wound care, cardiovascular imaging and over-the-counter products.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 5.3%
Div Cover -1.8
Op Mrgn -17.3%
ROCE n/a
Latest F'cast
P/E n/a
PEG n/a
Pr/Revenue 1.9
Pr/Book 5.6
Latest F'cast
Revenue 7.3%
PBT n/a
EPS n/a
DPS 4.8%

BMY Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 42,518.00 (6,871.00) (399.00)¢ n/a n/a n/a 184.00¢ 3.0%
31-Dec-21 46,385.00 8,098.00 315.00¢ 19.8 n/a n/a 201.00¢ 3.2%
31-Dec-22 46,159.00 7,713.00 297.00¢ 24.2 n/a -6% 219.00¢ 3.0%
31-Dec-23 45,006.00 8,440.00 388.00¢ 13.2 0.4 +31% 231.00¢ 4.5%
31-Dec-24 48,300.00 (8,379.00) (441.00)¢ n/a n/a n/a 242.00¢ 4.3%

BMY Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 47,440.86 15,532.82 640.56¢ 7.1 n/a n/a 247.40¢ 0.0%
31-Dec-26 43,517.66 15,306.07 605.11¢ 7.5 n/a -6% 254.85¢ 0.0%
31-Dec-27 43,046.82 15,210.16 590.25¢ 7.7 n/a -2% 262.73¢ 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

BMY ShareCast News

Bristol Myers Squibb delivers solid Q4 performan... 06-Feb-2025 ShareCast
Bristol Myers Squibb to cut 2,200 jobs as part o... 25-Apr-2024 ShareCast
Bristol Myers Squibb to buy Karuna Therapeutics ... 22-Dec-2023 ShareCast

BMY Top Newspaper Links

Bristol-Myers, partner AstraZeneca get EU approv... 06-Oct-2009 Chicago Tribune
AstraZeneca's heart attack drug offers £5.5bn bo... 31-Aug-2009 Sunday Telegraph
Astra Zeneca gets US approval for diabetes drug ... 02-Aug-2009 Sunday Times

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

BMY Market Data

Currency US Dollars
Share Price $ 46.20
Change Today $ 0.61
% Change 1.33 %
52 Week High $63.11
52 Week Low $42.60
Volume 4,897,687
Shares Issued 2,006.00m
Market Cap $92,667m
Beta 0.30
RiskGrade 106

What The Brokers Say

Strong Buy 3
Buy 3
Neutral 19
Sell 2
Strong Sell 0
Total 27
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 05-Nov-2025

Time Volume / Share Price
13:23 100 @ $46.20
13:23 200 @ $46.20
13:23 500 @ $46.20
13:23 100 @ $46.20
13:23 100 @ $46.20

Top of Page